Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
heart surgery surgeons

Baylor, others paying $15M over DOJ allegations they ‘gambled’ with heart patient health

According to a whistleblower, multiple Texas healthcare providers put complex heart surgeries in the hands of unqualified trainees without proper supervision. The $15M being recovered is the largest amount ever for a case of this kind. 

Vacant Walmart Health clinics attracting interest from insurers

Citing people familiar with the matter, a report said the retailer has spoken with Humana about potentially buying Walmart’s empty clinics.

Zachary Kon, MD, surgical director, advanced heart failure and cardiac transplantation at Hofstra/Northwell, explains the current standard for collecting and preserving organs and a the new concept of thoracoabdominal normothermic regional perfusion (NRP)

Advances in heart transplantation: Normothermic regional perfusion and beyond

Zachary Kon, MD, discussed the current standard for preserving organs and how NRP could lead to even better outcomes.

Jon Kobashigawa, MD, a veteran cardiologist with the Smidt Heart Institute at Cedars-Sinai, is the new president of the American Society of Transplantation (AST).

Cardiologist takes helm of American Society of Transplantation

Jon Kobashigawa, MD, head of the heart transplant program for Smidt Heart Institute at Cedars-Sinai, has been with AST since 2001.

Peter Monteleone, MD, an interventional cardiologist, national director of cardiovascular research at Ascension Health, and assistant professor, UT Austin Dell School of Medicine, explained the use of artificial intelligence (AI) to independently identify an emergency stroke or pulmonary embolism (PE) finding on a CT scan and automatically alert critical care team members. His health system uses this type of AI for earlier activation of the pulmonary embolism response team (PERT).

AI critical care software revolutionizes emergency response

Ascension Health in Texas uses AI that can read CT scans for stroke and pulmonary embolism to activate care teams before the images even get into the PACS.

CDC-funded program improved cardiovascular health of low-income Nebraska women

The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.

married marriage money fraud scandal

Brazen marital healthcare scheme ends with guilty pleas

A former Alabama doctor and her wife faced a slew of charges related to healthcare billing fraud, misuse of PPE loan funds and illegal distribution of opiates.

CityMD agrees to $12M settlement over alleged COVID claims fraud

The company cooperated with a DoJ investigation into COVID-19 tests being erroneously billed to the federal government.

Displaying 73 - 80 of 683

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup